Secondary endpoints were changes in carotid plaque score ( in six regions ) , measures of glycaemia ( HbA@c , fasting glucose , and insulin concentrations , and Homeostasis Model Assessment of Insulin Resistance -LSB- HOMA-IR -RSB- ) , and concentrations of lipids , high sensitivity C-reactive protein , and tissue plasminogen activator .